Plant Exosome-Like Nanovesicles Mitigate Sertoli Cell Injury
2026-06-07
This study reports that exosome-like nanovesicles derived from Cistanche deserticola can alleviate cyclophosphamide-induced testicular damage by targeting Sertoli cell cycle arrest. The work introduces a novel plant-derived intervention that modulates P21-CDK1 signaling, providing a foundation for advanced reproductive protection strategies.
Optimizing Protein Purification with X-press Tag Peptide
2026-06-06
X-press Tag Peptide streamlines recombinant protein workflows by combining high-yield affinity purification with precise antibody detection. Its advanced N-terminal leader design and robust solubility profile deliver reproducible, efficient results—even for challenging targets.
3X (DYKDDDDK) Peptide: Precision Tagging for Metal-Sensitive
2026-06-05
Explore the 3X (DYKDDDDK) Peptide as a robust epitope tag for affinity purification and immunodetection, with a unique focus on its metal-dependent properties and implications for advanced protein assays. Discover how this peptide enables new precision in recombinant protein workflows.
Dual-Action p38α MAPK Inhibitors Accelerate Dephosphorylatio
2026-06-05
This study reveals that certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings provide a new mechanistic basis for achieving improved specificity and potency in p38α MAPK inhibition, with direct implications for inflammation and autoimmune disease research.
Dual OXPHOS Disruption: LRPPRC Inhibition and Dasatinib Syne
2026-06-04
This study identifies a highly synergistic anti-tumor effect achieved by combining LRPPRC inhibition with dasatinib, targeting both mitochondrial and nuclear-encoded OXPHOS genes in cancer cells. The findings highlight a dual-genome strategy for more effective and specific disruption of tumor metabolism, offering translational potential for combination therapies in OXPHOS-dependent malignancies.
PNU 74654: Wnt Signaling Pathway Inhibitor for Advanced Rese
2026-06-04
PNU 74654 provides precise, reliable inhibition of the Wnt/β-catenin pathway, empowering researchers to dissect cell fate mechanisms in cancer and stem cell models. Its robust DMSO solubility and validated purity from APExBIO make it the trusted choice for reproducible, high-impact experiments.
Tofacitinib (CP-690550): Redefining Immune Cell Metabolism i
2026-06-03
Explore how Tofacitinib (CP-690550) uniquely modulates immune cell metabolism and mitochondrial health in rheumatoid arthritis models. This article provides an advanced, assay-focused perspective on JAK/STAT pathway inhibition for next-generation research.
Berberine Modulates SIRT6-AMPK to Prevent Ang II-Induced AF
2026-06-03
This study elucidates how berberine inhibits NLRP3 inflammasome activation by upregulating the SIRT6-AMPK pathway, thereby preventing angiotensin II-induced atrial fibrosis and reducing susceptibility to atrial fibrillation (AF). The findings highlight a mechanistic link between metabolic stress signaling, inflammasome activity, and AF pathogenesis, offering a framework for targeted research in cardiac remodeling and immunometabolism.
Saracatinib (AZD0530): Reliable Src/Abl Inhibition for Cell
2026-06-02
This article provides an evidence-based, scenario-driven exploration of Saracatinib (AZD0530), SKU A2133, for researchers tackling cell viability, proliferation, and migration assays. Through real-world Q&A, we address experimental challenges and detail how APExBIO's Saracatinib delivers reproducibility and mechanistic clarity in cancer biology research.
D-N-Acetylgalactosamine: Technical Use in Neurological Glyco
2026-06-02
D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite used for analyzing glycoprotein constituents and glycosylation pathways in brain tissue research. It is ideal for workflows requiring aqueous or DMSO solubility, but is unsuitable for ethanol-based protocols or long-term solution storage. Proper handling and adherence to protocol parameters are essential to maintain experimental reliability.
Synergistic Antibiotic Combinations Against Mycobacterium av
2026-06-01
This article reviews a pivotal in vitro study evaluating the efficacy of clarithromycin, temafloxacin, and ethambutol—singly and in combination—against Mycobacterium avium complex isolates. The findings provide mechanistic insight into combination therapy strategies and inform experimental approaches to intracellular antibacterial activity in mycobacterial infection models.
DGLA-Induced Ferroptosis in AML via ACSL4-Mediated Lipid Rep
2026-06-01
This study reveals that exogenous dihomo-γ-linolenic acid (DGLA) can trigger ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight a potential therapeutic avenue for overcoming apoptosis resistance in AML by targeting ferroptotic pathways.
SU 5402: Precision Tyrosine Kinase Inhibitor for Translation
2026-05-31
SU 5402 empowers researchers to dissect tyrosine kinase signaling in cancer and neuronal models with nanomolar potency and workflow reproducibility. Explore actionable protocols, advanced applications, and troubleshooting insights that set SU 5402 apart in multiple myeloma and neuron-based disease modeling.
Staurosporine in Precision Apoptosis Modeling: Advanced Assa
2026-05-30
Discover how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, enables unprecedented precision in cell death assays. This in-depth guide uniquely bridges molecular mechanism with translational workflow optimization for cancer and liver research.
Tioconazole in Antifungal Research: Integrative Mechanistic
2026-05-29
Explore the unique antifungal mechanism of Tioconazole and its role in cutting-edge fungal infection research. This article offers advanced scientific analysis, linking ergosterol biosynthesis inhibition with the latest findings in cellular metabolism.
458 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page